Proliferation of mesenchymal stem cells

The phrase "Proliferation of mesenchymal stem cells" refers to a biological process—specifically, the expansion of mesenchymal stem cells (MSCs) in culture or in vivo through cell division—rather than a specific molecule, receptor, enzyme, or other molecular entity that can be targeted by drugs. As such, it is not considered a "target" in the pharmacological sense (a macromolecule to which a drug binds to exert a therapeutic effect). The regulation of MSC proliferation involves multiple signaling pathways and transcription factors (e.g., BMP, Wnt, Hedgehog, TGFβ, FGF)[2][4], but these are the actual molecular targets, not "proliferation" itself. If the goal is to identify true therapeutic targets that modulate MSC proliferation, one should instead specify the relevant molecule (e.g., Wnt receptor, BMP receptor, Hedgehog receptor, etc.) or pathway involved in MSC expansion. As it stands, "Proliferation of mesenchymal stem cells" is a process, not a target, and cannot be mapped to a structured entry for a drug target database. If you need structured information on pathways or molecules regulating MSC proliferation, please specify one of those molecular entities (e.g., "Wnt receptor," "Bone morphogenetic protein receptor," etc.).